NutraLife BioSciences, Inc. (NLBS)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue - 626.61 Thousand 1.25 Million 2.13 Million 3.71 Million 1.79 Million
Cost of Revenue - 543.03 Thousand 745.93 Thousand 1.53 Million 2.21 Million 1.05 Million
Gross Profit - 83.58 Thousand 509.85 Thousand 598.13 Thousand 1.5 Million 735.12 Thousand
Operating Expenses - 4.55 Million 2.48 Million 3.99 Million 3.4 Million 21.02 Million
Selling, General and Administrative Expenses - 4.44 Million 2.48 Million 3.99 Million 3.4 Million 20.94 Million
Research and Development Expenses - - - - - -
Other Expenses - 114.43 Thousand -53.00 58.02 Thousand -34.74 Thousand 1951.00
Cost and Expenses - 5.09 Million 3.22 Million 5.52 Million 5.61 Million 22.07 Million
Operating Income - -4.47 Million -1.97 Million -3.39 Million -1.9 Million -20.28 Million
Interest Expense - 1.84 Million 12.79 Thousand 7925.00 133.75 Thousand 3.34 Million
Income Tax Expense - 1.85 Million 12.74 Thousand 65.94 Thousand 168.49 Thousand 3.33 Million
Earnings before Tax - -5.82 Million -2.88 Million -4 Million -2.07 Million -23.62 Million
Net Income - -7.68 Million -2.9 Million -4.07 Million -2.07 Million -23.62 Million
Earnings Per Share Basic - -0.05 -0.02 -0.04 -0.02 -0.33
Earnings Per Share Diluted - -0.05 -0.02 -0.04 -0.02 -0.33
Weighted Average Shares Outstanding - 164.52 Million 146.33 Million 113.27 Million 87.32 Million 71.82 Million
Weighted Average Shares Outstanding (Diluted) - 164.52 Million 146.33 Million 113.27 Million 87.32 Million 71.82 Million
Gross Margin - 0.13 0.41 0.28 0.40 0.41
EBIT Margin - -6.61 -1.98 -1.77 -0.51 -11.29
Profit Margin - -12.26 -2.31 -1.91 -0.56 -13.20
EBITDA - -3.65 Million -1.57 Million -3.76 Million -1.87 Million -20.2 Million
Earnings Before Tax Margin - -7.14 -1.57 -1.59 -0.51 -11.33

Income Statement Charts